Interpace Biosciences, Inc. (IDXG)
OTCMKTS
· Delayed Price · Currency is USD
1.740
-0.010 (-0.57%)
At close: Mar 6, 2026
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $48.19 million as of March 6, 2026. Its market cap has increased by 1,662.50% in one year.
Market Cap
48.19M
Enterprise Value
49.02M
Revenue
41.92M
Ranking
n/a
PE Ratio
16.04
Stock Price
$1.74
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 48.19M, a decrease of -78.29%. That is a compound annual growth rate of -5.34%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioqual | 33.55M |
| China New Energy Group Company | 80.77M |
| Global Cord Blood | 127.22M |
| Longduoduo Company | 15.31M |
| Aspira Women's Health | 14.35M |
| Psychemedics | 9.18M |
| Hypha Labs | 4.96M |
| Stella Diagnostics | 4.82M |